Vancomycin injection recalled due to sterility assurance concerns
Central Admixture Pharmacy Services is recalling vancomycin injections (1 g/250 mL) nationwide due to concerns about sterility assurance identified during FDA inspection. The recall affects 4,390 bags.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is a FDA Class II recall with no reported hospitalizations, illnesses, or injuries. The hazard—lack of sterility assurance for an injectable medication—poses a theoretical risk of harm, placing it in the High severity category per the rubric.
Plain-English summary
Central Admixture Pharmacy Services, Inc. is recalling vancomycin injections (1 g/250 mL, 4 mg/mL) distributed nationwide. The recall affects 4,390 bags across multiple lot numbers.
The FDA inspection questioned the sterility assurance of these products. Vancomycin is a prescription injectable medication that must be sterile to be safe for use.
The affected lots were distributed nationwide. Consumers and healthcare providers who have received products with the following lot numbers should stop using them: Lot #37-885351 (Exp 05/08/2023), 37-885979 (Exp 05/10/2023), 37-887721 (Exp 05/17/2023), 37-889212 (Exp 05/23/2023), 37-889607 (Exp 05/24/2023), 37-891247 (Exp 05/31/2023), 37-892937 (Exp 06/07/2023), 37-894025 (Exp 06/12/2023), 37-894748 (Exp 06/14/2023), 37-895282 (Exp 06/18/2023), 37-896173 (Exp 06/20/2023).
If you or your healthcare provider have used this medication, speak with a healthcare provider. Do not use any remaining product with the recalled lot numbers. Contact Central Admixture Pharmacy Services or the FDA with questions.
The recalled product
- Product
- vancomycin added to 0.9% sodium chloride, 1 g/250 mL* (4 mg/mL), 25 250 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., 6580 Snowdrift Rd., Ste 100, Allentown, PA 18106, NDC 71285-6064-1.
- Manufacturer
- Central Admixture Pharmacy Services, Inc.
- Category
- Drug — Injectable / Antibiotic
- Affected units
- 4,390
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- Lot # 37-885351
- Exp 05/08/2023
- 37-885979
- Exp 05/10/2023
- 37-887721
- Exp 05/17/2023
- 37-889212
- Exp 05/23/2023
- 37-889607
- Exp 05/24/2023
- 37-891247
- Exp 05/31/2023
- 37-892937
- Exp 06/07/2023
- 37-894025
- Exp 06/12/2023
- 37-894748
- Exp 06/14/2023
- 37-895282
- Exp 06/18/2023
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 108 recalled by Central Admixture Pharmacy Services, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 108 products in this recall →Related recalls
Same manufacturer · Central Admixture Pharmacy Services, Inc.
See all →- ModeratePediatric TPN Bags Recalled for Incorrect Formulation
FDA (Drugs) · 2026-08-12
- SeverePediatric Total Parenteral Nutrition Bag Recalled for Incorrect Formulation
FDA (Drugs) · 2026-07-01
- SevereInjectable Phenylephrine Solution Recalled Due to Particulate Matter Contamination
FDA (Drugs) · 2025-03-19
- HighInjectable Lidocaine Recalled Due to Lack of Sterility Assurance
FDA (Drugs) · 2023-10-11
- HighMidazolam Injectable Solution Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2023-10-11